3 S&P 500 Stocks We Keep Off Our Radar
3 Stocks Under $50 We’re Skeptical Of
5 Must-Read Analyst Questions From Viatris’s Q2 Earnings Call
VTRS Q2 Deep Dive: China Growth, Pipeline Progress, and Margin Concerns Shape Outlook
Viatris (NASDAQ:VTRS) Posts Better-Than-Expected Sales In Q2 CY2026
PITTSBURGH , Aug. 6, 2026 /PRNewswire/ -- Viatris Inc . (Nasdaq: VTRS), a global healthcare company, today announced its second-quarter 2026 financial results.
Barchart Research What to Expect from VTRS Earnings VTRS Generated August 5, 2026 Current Price $17.65 EPS Estimate $$0.62 Consensus Rating Moderate Buy Average Move 8.55% Viatris Reports Tomorrow With...
Viatris (VTRS) Q2 Earnings Report Preview: What To Look For
Though Viatris has outpaced the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.